Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

“My vision is that every American is wearing a wearable within four years,” he said at a congressional hearing last week. It ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

For instance, you’ve likely heard of "Ozempic face," "Ozempic feet," and even "Ozempic mouth," but what about "skinny fat?" The term was coined on the inaugural episode of the Scrubs to Stilettos ...

GLP-1 drugs like Ozempic® and Zepbound®, have gained significant attention in recent years for treating both diabetes and ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed ...